No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
NUS240816C10000
- 0.50
- -0.65-56.52%
15min DelayClose Jul 22 16:00 ET
0.50High0.50Low
0.50Open1.15Pre Close5 Volume10 Open Interest10.00Strike Price250.00Turnover57.59%IV3.55%PremiumAug 16, 2024Expiry Date0.14Intrinsic Value100Multiplier25DDays to Expiry0.36Extrinsic Value100Contract SizeAmericanOptions Type0.5759Delta0.2546Gamma14.49Leverage Ratio-0.0128Theta0.0036Rho8.34Eff Leverage0.0105Vega
Intraday
- 5D
- Daily
News
Nu Skin Enterprises to Announce Second Quarter 2024 Financial Results
Nu Skin Enterprises, Inc. (NYSE:NUS) today announced it will release second quarter 2024 results after the market closes on Thursday, Aug. 8. The Nu Skin management team will host a conference call with the investment
Form 144 | Nu Skin Enterprises(NUS.US) Insider Proposes to Sell 165.52K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 24, $Nu Skin Enterprises(NUS.US)$ Insider LIPMAN ANDREW D intends to sell 13,312 shares of its common stock on Jun 21, with a total market value of approximately $165.52K.
Nu Skin Enterprises (NYSE:NUS Shareholders Incur Further Losses as Stock Declines 7.7% This Week, Taking Three-year Losses to 76%
It's not possible to invest over long periods without making some bad investments. But really big losses can really drag down an overall portfolio. So spare a thought for the long term shareholders
Global Aromatherapy Market Size To Exceed USD 18.5 Billion By 2033 | CAGR of 9.45%
Express News | NYSE Order Imbalance 52017.0 Shares on Buy Side
Express News | NYSE Order Imbalance 134990.0 Shares on Sell Side
Comments
Nu Skin Enterprises' low P/S ratio is likely due to anticipated poor revenue performance. Its shrinking revenues and weak outlook, contrasting with expected industry growth, justify its low P/S ratio and hint at a stagnant share price.
Analysts are more bearish on Nu Skin Enterprises' prospects, with a significant cut to revenue and EPS estimates. The company's slower expected revenue growth compared to the wider market could worry investors.
Read more